• Posts by Gerald B. Halt Jr.
    Shareholder

    Clients appreciate Jay’s holistic and inventive approach to optimizing the value of their intellectual property portfolios. He collaborates with clients at all stages of development—from startup entrepreneurs to teams of ...

As the Machine Learns- Continuing Artificial Intelligence IP and Privacy Considerations

Artificial Intelligence (AI) is everywhere these days, from personal assistants to self-driving cars. With the continuous introduction of new technology, the use of artificial intelligence in business has been growing rapidly, and in ways that people have never imagined. AI is used in many software products and services, and is also being integrated into manufacturing processes. AI frequently automates routine tasks that were previously performed by people, eliminating tedious work, making business processes more efficient, and creating new capabilities and ... Read More ›

If a startup company wants to become an established, successful business, the company needs to carefully manage all of its resources, both tangible and intangible, in the same manner as an established, successful business – focusing meticulously on maximizing the return on every expenditure. If the company is founded on proprietary technology, carefully planning an intellectual property (IP) strategy as part of the business plan is critical. A well-managed and organized IP portfolio is attractive to potential investors at all stages of a business’s development and can be ... Read More ›

Contradictory FDA/USPTO Regulatory Requirements? Belcher’s Missteps Results in Loss of Patent Rights

Companies face many hurdles when bringing a new product to market, including technical problems, regulatory requirements and changing market forces. Introducing a new drug or medical device to the market introduces additional regulatory hurdles before both the Food and Drug Administration (FDA) and the US Patent and Trademark Office (USPTO). The strategies for meeting these regulatory requirements may often seem contradictory, and can be a trap for the unwary.  This ultimately doomed the Belcher Pharmaceutical patent as will be explained in detail below.

When filing a patent ... Read More ›

Startup Case Study: ThePureBag™

When Lori Gildea became seriously ill, a close examination of her routine and symptoms led doctors to the likely culprit: her gym bag. Unbeknownst to her at the time, her gym bag had undergone a transformation from functional accessory to blossoming petri dish. As she regained her health and strength, Lori looked for ways to prevent another bacteria-induced sickness from disrupting (and jeopardizing) her life, as well as the lives of other active individuals. Her pursuit for a safer, cleaner and healthier workout bag led to ThePureBag™.

Lori wanted a solution to keep workout gear ... Read More ›

Posted in: Startups

The landscape for patent law has changed more quickly over the last five years than it had in preceding decades. The America Invents Act, which was enacted in September 2011, may be the most comprehensive and significant change to patent law in decades, and recent case law appears to be accelerating changes. For example, Mayo Collaborative Services. v. Prometheus Labs, 566 U.S. 66 (2012), changed how patent-eligible subject matter is determined and what currently is patentable eligible. Alice v. CLS Bank International, 134 S. Ct. 2347 (2014), dramatically changed the landscape for ... Read More ›

Posted in: Patents

Subscribe

Subscribe

* indicates required
/ ( mm / dd )
RSS RSS Feed

Recent Posts

Archives

Jump to Page

By using this site, you agree to our updated Privacy Policy & Disclaimer.